(1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol

C20H32O3 — CID 163191326

IUPAC(1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol
SMILESC=C(C)[C@H]1C[C@H]2O[C@H]1C/C(C)=C/CC[C@]1(C)O[C@H]1CC[C@]2(C)O
InChIInChI=1S/C20H32O3/c1-13(2)15-12-18-19(4,21)10-8-17-20(5,23-17)9-6-7-14(3)11-16(15)22-18/h7,15-18,21H,1,6,8-12H2,2-5H3/b14-7+/t15-,16+,17+,18-,19+,20+/m1/s1
InChIKeyUORKGCGVAYLWPF-OWPNWBAQSA-N
MW320.47 g/mol
LogP4.16
Rot. Bonds1

About (1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol

(1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol (PubChem CID 163191326) has the molecular formula C20H32O3 and a molecular weight of 320.47 g/mol. Its IUPAC name is (1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol.

Molecular Properties

Compound Name(1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol
PubChem CID163191326
Molecular FormulaC20H32O3
Molecular Weight320.47 g/mol
Exact Mass320.24
IUPAC Name(1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol
SMILESC=C(C)[C@H]1C[C@H]2O[C@H]1C/C(C)=C/CC[C@]1(C)O[C@H]1CC[C@]2(C)O
InChIInChI=1S/C20H32O3/c1-13(2)15-12-18-19(4,21)10-8-17-20(5,23-17)9-6-7-14(3)11-16(15)22-18/h7,15-18,21H,1,6,8-12H2,2-5H3/b14-7+/t15-,16+,17+,18-,19+,20+/m1/s1
InChIKeyUORKGCGVAYLWPF-OWPNWBAQSA-N
XLogP4.16
TPSA41.99 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds1
Heavy Atoms23
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500320.47
LogP ≤ 54.16
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze (1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol?
The IUPAC name of (1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol (CID 163191326) is (1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol.
What is the SMILES notation for (1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol?
The canonical SMILES for (1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol is C=C(C)[C@H]1C[C@H]2O[C@H]1C/C(C)=C/CC[C@]1(C)O[C@H]1CC[C@]2(C)O.
What is the InChIKey of (1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol?
The InChIKey is UORKGCGVAYLWPF-OWPNWBAQSA-N. The full InChI is InChI=1S/C20H32O3/c1-13(2)15-12-18-19(4,21)10-8-17-20(5,23-17)9-6-7-14(3)11-16(15)22-18/h7,15-18,21H,1,6,8-12H2,2-5H3/b14-7+/t15-,16+,17+,18-,19+,20+/m1/s1.
What are the key properties of (1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol?
(1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol has a molecular weight of 320.47 g/mol, XLogP of 4.16, 1 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,2S,5S,7S,10E,13S,14R)-2,7,11-trimethyl-14-prop-1-en-2-yl-6,16-dioxatricyclo[11.2.1.05,7]hexadec-10-en-2-ol is sourced from PubChem (CID 163191326), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).